Cargando…
HIV Prevention After Discontinuing Pre-Exposure Prophylaxis: Conclusions From a Case Study
Pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate in combination with emtricitabine (FTC) is a highly effective form of HIV prevention. Endeavors of health-care providers and activists in many countries over the world are directed at making access to PrEP possible, or increasing PrE...
Autores principales: | Jonas, Kai J., Yaemim, Natthakhet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954039/ https://www.ncbi.nlm.nih.gov/pubmed/29868545 http://dx.doi.org/10.3389/fpubh.2018.00137 |
Ejemplares similares
-
Factors Predicting Uptake of Sexually Transmitted Infections Testing among Men Who Have Sex with Men Who Are “Pre-Exposure Prophylaxis Tourists”—An Observational Prospective Cohort Study
por: Wang, Zixin, et al.
Publicado: (2021) -
Pre-exposure Prophylaxis: The Delivery Challenge
por: Venter, Willem D. F.
Publicado: (2018) -
Real-life cohort experience after implementing HIV pre-exposure prophylaxis for one year in northwest Spain
por: Pérez-González, Alexandre, et al.
Publicado: (2022) -
Health Care Worker Perspectives of HIV Pre-exposure Prophylaxis Service Delivery in Central Uganda
por: Muwonge, Timothy R., et al.
Publicado: (2022) -
Exploring the Use of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among High-Risk People Who Use Drugs in Treatment
por: Shrestha, Roman, et al.
Publicado: (2018)